Trial intelligence / Profile preview

Varenicline in Heavy Drinking Smokers

NCT02488889Phase 4Withdrawn

Sponsor
University of California, Los Angeles
Start
Aug 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of varenicline in nicotine dependence, sponsored by University of California, Los Angeles. Planned start Aug 2015; status: withdrawn.

02

Drugs

varenicline
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT02488889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02488889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call